Last Updated on: Apr 24, 2025
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
Period | |
---|---|
23 Apr 15:30 | 1411.25 |
* All values are in ₹Rupees
P/E Ratio Over Time
<p style=font-size: 14px;> The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. </p><br> <h3>P/E Ratio Formula</h3><br> <p style=font-size: 14px;>P/E ratio = (CMP of share/ Earning per share)</p><br> <h3>Types of Price to Earning Ratio</h3><br> <p style=font-size: 14px;>1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.<br> 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.</p>
No data available
Market Cap Over Time
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
No data available
* All values are in ₹ crore
* All values are in Rupees
Revenue Over Time
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.
No data available
* All values are in ₹ crore
EBITDA Over Time
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
No data available
* All values are in ₹ crore
Net Profit Over Time
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue
No data available
* All values are in ₹ crore
Dividend Payout Over Time
Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.
No data available
* All values are in %
Glenmark Pharma's US arm set to launch generic Adderall tablets
The company will launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroampheta...
17 Apr 2025 08:04
Glenmark Pharmaceuticals allots 12,653 equity shares under ESOP
Glenmark Pharmaceuticals has allotted 12,653 equity shares under ESOP. Consequently, the p...
17 Apr 2025 20:08
Glenmark USA to launch Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the upcoming launch of Dextroamphe...
16 Apr 2025 19:53
Glenmark Pharmaceuticals Ltd slips for fifth straight session
Glenmark Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quot...
11 Apr 2025 13:35
Glenmark Pharmaceuticals announces change in senior management
Glenmark Pharmaceuticals has appointed Anurag Mantri as President (Senior Management Perso...
07 Apr 2025 09:00
Glenmark Pharmaceuticals launches Vancomycin Hydrochloride for Injection USP
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the launch of Vancomycin Hydrochlo...
01 Apr 2025 09:40
Lupin gets EIR from USFDA for Nagpur facility
The EIR was issued following an inspection of the facility conducted from 10 June to 13 Ju...
17 Apr 2025 15:00
Lupin allots 24,101 equity shares under ESOP
Lupin has allotted 24,101 equity shares under ESOP on 21 March 2025. In view of the above,...
21 Mar 2025 16:10
Nanomi wins prestigious CMO Award for Life Science Leadership in Drug Delivery
Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin, today announced that it ...
21 Mar 2025 19:12
Lupin gains after getting tentative USFDA approval for Amifampridine tablets 10 mg
Amifampridine Tablets, 10 mg, are bioequivalent to Firdapse Tablets, 10 mg, from Catalyst ...
17 Mar 2025 10:44
Lupin receives USFDA tentative approval for Amifampridine Tablets
Lupin has received tentative approval from the United States Food and Drug Administration ...
17 Mar 2025 13:36
Lupin launches Rivaroxaban drug in US
The newly launched drug is bioequivalent to Xarelto 2.5 mg from Janssen Pharmaceuticals, I...
10 Mar 2025 10:02
Strength
3
S
Weakness
2
W
Opportunity
0
O
Threats
1
T
Strength
4
S
Weakness
2
W
Opportunity
1
O
Threats
1
T
Revenue
Profitability
Affordability
Liquidity
Dividend
Revenue
Profitability
Affordability
Liquidity
Dividend
Unlimited trading starting at just Rs. 249*